Ultragenyx Pharmaceutical (RARE) Stock Chart & Stock Price History → Never use this word on your phone (FBI could be watching) (From Paradigm Press) (Ad) Free RARE Stock Alerts $42.75 -0.45 (-1.04%) (As of 05/3/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Ultragenyx Pharmaceutical Stock Price Performance5 Day Performance-3.37%1 Month Performance-9.20%3 Month Performance-0.63%6 Month Performance+10.10%Year-To-Date Performance-10.60%1 Year Performance-1.34% Receive RARE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ultragenyx Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlace$21,000 in profits in six weeks? On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.Click here for details. RARE Stock Chart for Saturday, May, 4, 2024 RARE Chart by TradingView Ultragenyx Pharmaceutical Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/03/2024$43.20$42.75-1.04%$46.01$42.681.14 million shs$3.55 billion05/02/2024$43.30$43.20-0.23%$44.02$42.39804,085 shs$3.59 billion05/01/2024$42.54$43.30+1.79%$44.11$42.251.61 million shs$3.60 billion04/30/2024$44.02$42.54-3.36%$44.32$42.51714,710 shs$3.50 billion04/29/2024$44.24$44.02-0.50%$45.36$43.92625,791 shs$3.62 billion04/26/2024$43.85$44.24+0.89%$44.58$43.71450,422 shs$3.64 billion Get the Latest News and Ratings for RARE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ultragenyx Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 04/25/2024$44.28$43.85-0.97%$44.00$42.73470,806 shs$3.61 billion04/24/2024$45.11$44.28-1.84%$45.55$43.61668,679 shs$3.64 billion04/23/2024$43.69$45.11+3.25%$45.58$43.13836,693 shs$3.71 billion04/22/2024$42.37$43.69+3.12%$44.44$42.40592,367 shs$3.60 billion04/19/2024$43.38$42.37-2.33%$43.92$41.07675,380 shs$3.49 billion04/18/2024$44.11$43.38-1.65%$44.80$43.32765,767 shs$3.57 billion04/17/2024$42.31$44.11+4.25%$44.63$42.25890,196 shs$3.63 billion04/16/2024$42.87$42.31-1.31%$44.17$42.21886,829 shs$3.48 billion04/15/2024$47.00$42.87-8.79%$44.54$42.011.73 million shs$3.53 billion04/12/2024$50.70$47.00-7.30%$50.64$46.81784,218 shs$3.87 billion04/11/2024$51.61$50.70-1.76%$52.56$50.35635,261 shs$4.17 billion04/10/2024$50.56$51.61+2.08%$51.68$49.41559,765 shs$4.25 billion04/09/2024$50.23$50.56+0.66%$51.24$50.24530,495 shs$4.16 billion04/08/2024$50.24$50.23-0.02%$51.20$49.21488,911 shs$4.13 billion04/05/2024$47.08$50.24+6.71%$50.78$45.83981,019 shs$4.13 billion04/04/2024$47.08$47.08$49.50$47.04554,436 shs$3.87 billion04/03/2024$46.59$47.08+1.05%$47.50$45.71620,664 shs$3.87 billion04/02/2024$46.97$46.59-0.81%$46.70$45.24815,146 shs$3.83 billion04/01/2024$46.69$46.97+0.60%$47.04$45.72578,319 shs$3.87 billion03/29/2024$46.69$46.69$47.12$46.28543,698 shs$3.84 billion03/28/2024$46.82$46.69-0.28%$47.12$46.28543,698 shs$3.84 billion03/27/2024$45.46$46.82+2.99%$47.16$45.55527,648 shs$3.85 billion03/26/2024$45.42$45.46+0.09%$46.24$45.01362,334 shs$3.74 billion03/25/2024$45.85$45.42-0.94%$46.31$45.02442,707 shs$3.77 billion03/22/2024$46.65$45.85-1.71%$47.05$45.56403,664 shs$3.77 billion03/21/2024$47.01$46.65-0.77%$47.94$46.63473,570 shs$3.84 billion03/20/2024$47.00$47.01+0.02%$47.26$46.35516,842 shs$3.87 billion03/19/2024$46.59$47.00+0.88%$47.37$46.11892,358 shs$3.87 billion03/18/2024$47.37$46.59-1.65%$47.94$46.53853,866 shs$3.83 billion03/15/2024$46.65$47.37+1.54%$47.63$46.221.79 million shs$3.90 billion03/14/2024$48.55$46.65-3.91%$48.07$46.481.09 million shs$3.84 billion03/13/2024$47.66$48.55+1.87%$49.27$47.60847,957 shs$4.00 billion03/12/2024$48.51$47.66-1.75%$48.76$47.32549,006 shs$3.92 billion03/11/2024$50.53$48.51-4.00%$50.95$48.40639,244 shs$3.99 billionNever use this word on your phone (FBI could be watching) (Ad)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...Watch my unredacted video about what I think is coming next right here03/08/2024$50.85$50.53-0.63%$51.74$50.16501,014 shs$4.16 billion03/07/2024$51.26$50.85-0.80%$52.09$50.49554,596 shs$4.19 billion03/06/2024$51.47$51.26-0.41%$51.77$50.89435,079 shs$4.22 billion03/05/2024$53.31$51.47-3.45%$53.25$50.14790,575 shs$4.24 billion03/04/2024$53.69$53.31-0.71%$53.77$52.01692,791 shs$4.39 billion03/01/2024$51.72$53.69+3.81%$54.55$52.03743,828 shs$4.42 billion02/29/2024$52.75$51.72-1.95%$54.39$51.691.35 million shs$4.26 billion02/28/2024$53.66$52.75-1.70%$54.48$52.58924,092 shs$4.34 billion02/27/2024$50.25$53.66+6.79%$53.90$50.73910,704 shs$4.42 billion02/26/2024$49.48$50.25+1.56%$50.71$49.09553,606 shs$4.14 billion02/23/2024$48.88$49.48+1.23%$50.20$48.75454,393 shs$4.06 billion02/22/2024$48.18$48.88+1.45%$49.36$47.49395,382 shs$4.01 billion02/21/2024$47.87$48.18+0.65%$48.53$47.67456,533 shs$3.96 billion02/20/2024$48.92$47.87-2.15%$49.73$47.29706,673 shs$3.93 billion02/19/2024$48.92$48.92$49.57$46.581.08 million shs$4.02 billion02/16/2024$46.26$48.92+5.75%$49.57$46.581.08 million shs$4.02 billion02/15/2024$45.66$46.26+1.31%$47.08$45.82843,457 shs$3.80 billion02/14/2024$43.98$45.66+3.82%$45.93$44.40583,574 shs$3.75 billion02/13/2024$46.74$43.98-5.91%$45.39$43.69584,218 shs$3.61 billion02/12/2024$46.73$46.74+0.02%$47.82$46.46614,574 shs$3.84 billion02/09/2024$45.45$46.73+2.82%$47.13$45.17431,974 shs$3.84 billion02/08/2024$44.71$45.45+1.66%$45.66$44.79652,729 shs$3.73 billion02/07/2024$45.89$44.71-2.57%$45.91$44.59496,896 shs$3.67 billion02/06/2024$44.76$45.89+2.52%$45.96$44.45733,372 shs$3.77 billion02/05/2024$43.02$44.76+4.04%$44.98$42.37710,096 shs$3.68 billion02/02/2024$44.10$43.02-2.45%$43.73$42.62621,299 shs$3.53 billion Related Companies: Crinetics Pharmaceuticals Stock Price Chart Prestige Consumer Healthcare Stock Price Chart Biohaven Stock Price Chart Insmed Stock Price Chart CymaBay Therapeutics Stock Price Chart HUTCHMED Stock Price Chart Bausch Health Companies Stock Price Chart Xenon Pharmaceuticals Stock Price Chart IDEAYA Biosciences Stock Price Chart Amicus Therapeutics Stock Price Chart Receive RARE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ultragenyx Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RARE) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchStock-Picking AI Predicts #1 Stock of 2024AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe asset beating inflation by 4xColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ultragenyx Pharmaceutical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.